Meeting Details

The 39th Annual General Meeting of Aurobindo Pharma Limited was held on Thursday, August 27, 2026, at 3:30 p.m. through video conferencing (VC) facility/other audio-visual means (OAVM). The meeting was conducted in compliance with the Companies Act, 2013, SEBI (Listing Obligations and Disclosures Requirements) Regulations, 2015, and MCA Circulars including General Circular No. 14/2020 dated April 8, 2020, and Circular No. 3/2025 dated September 22, 2025.

Attendance

  • 86 members attended the meeting through VC/OAVM
  • Directors present: Mr. M.R. Kumar (Chairman, Independent Director), Mr. K. Nithyananda Reddy (Vice Chairman & Managing Director), Mr. M. Madan Mohan Reddy (Whole-time Director), Mr. P. V. Ramprasad Reddy (Director), Mr. P. Sarath Chandra Reddy (Director), Mr. Girish Paman Vanvari (Independent Director), Mr. Santanu Mukherjee (Independent Director), Dr. M. Satakarni Makkapati (Director), Dr. (Mrs.) Punita Kumar Sinha (Independent Director)
  • In attendance: Mr. C. Manish Muralidhar (Statutory Auditors, Deloitte Haskins & Sells), Mr. A. Mohan Rami Reddy (Secretarial Auditor), Mr. S. Subramanian (Chief Financial Officer)

Business Transacted

The following agenda items from the Notice dated May 21, 2026, were transacted:

Ordinary Business:

1. Adoption of Audited Standalone Financial Statements for FY ended March 31, 2026, and reports of Board of Directors and Auditors thereon (Ordinary Resolution)

2. Adoption of Audited Consolidated Financial Statements for FY ended March 31, 2026, together with report of Auditors thereon (Ordinary Resolution)

3. Confirmation of interim dividend of ₹4 per equity share of Re.1 paid for financial year 2025-26 (Ordinary Resolution)

4. Reappointment of Mr. K. Nithyananda Reddy (DIN: 01284195) who retires by rotation (Ordinary Resolution)

5. Reappointment of Dr. M. Madan Mohan Reddy (DIN: 01284266) who retires by rotation (Ordinary Resolution)

Special Business:

6. Appointment of Secretarial Auditor of the Company (Ordinary Resolution)

Voting Process

Remote e-voting commenced at 9:00 a.m. (IST) on Monday, August 24, 2026, and closed at 5:00 p.m. (IST) on Wednesday, August 26, 2026. Voting rights were proportional to shares in paid-up equity share capital as of the cut-off date Thursday, August 20, 2026. Electronic voting during the AGM was available for 15 minutes from the conclusion of the meeting for members who had not voted remotely.

Mr. Y. Ravi Prasada Reddy, Practicing Company Secretary (proprietor of RPR & Associates), was appointed as Scrutinizer to conduct the voting process in a fair and transparent manner.

Additional Information

The Chairman addressed shareholders about the company's financial performance and future growth plans. Necessary clarifications were provided for shareholder queries on annual performance and AGM agenda.

The integrated Annual Report for FY 2025-26 containing Notice of AGM, Board's Report, standalone & consolidated financial statements with Auditors' reports was sent electronically to members with registered email addresses. For members without email registration, a letter with weblink details and QR code to access the Annual Report was sent.

Statutory registers and Secretarial Auditor's Report were available for inspection at the meeting.

Outcome Declaration

The consolidated results of remote e-voting and e-voting at the AGM will be declared within two working days of the conclusion of the AGM. The results and scrutinizer's report will be submitted to BSE Limited and National Stock Exchange of India Limited, and posted on the company's website (www.aurobindo.com) and KFintech's website (www.evoting.kfintech.com).

The meeting concluded at 4:44 p.m.